Mindfulness-Based Exercise Video in Educating Hispanic/Latino Patients With Colorectal Cancer and Their Caregivers
- Conditions
- FatigueRectal CancerAnxiety DisorderDepressionColon Cancer
- Interventions
- Other: educational interventionProcedure: CAM exercise therapyOther: caregiver-related intervention or procedureOther: questionnaire administrationOther: laboratory biomarker analysis
- Registration Number
- NCT02057991
- Lead Sponsor
- University of Southern California
- Brief Summary
This randomized pilot trial studies mindfulness-based program in educating patients with colorectal cancer and their caregivers. A mindfulness-based exercise video may help reduce stress and fatigue in patients with colorectal cancer and their caregivers.
- Detailed Description
PRIMARY OBJECTIVES:
I. To evaluate the effect of a brief educational program on colorectal cancer knowledge acquisition in a 3-arm randomized clinical trial (Control Group: standard of care; Treatment Group 1: cancer education; Treatment Group 2: mindfulness + cancer education) comparing visual/written educational material with and without mindfulness training to the standard of care.
II. To determine the priming effect of a brief mindfulness training on retaining knowledge of colorectal cancer education.
III. To determine the joint effect of colorectal cancer education delivered to both the patient and a caregiver on the overall colorectal cancer knowledge.
SECONDARY OBJECTIVES:
I. To examine the relative changes in psychobiological variables (stress, anxiety, depression, mindfulness, fatigue, life benefit) from pre (T0) to post (T1) intervention in the 3 arms of the clinical trials.
II. To measure changes in salivary cortisol levels as an indicator of acute stress reactivity across 4 time points across a one-hour period (i.e., 0 min, 20 min, 40 min, 60 min) during active chemotherapy (T1).
III. To determine the moderating effect of baseline peripheral levels of inflammation (interleukin-1 \[IL-1\], IL-6, c-reactive protein \[CRP\] and tumor necrosis factor alpha \[TNFa\]) on the trajectory of salivary cortisol reactivity.
OUTLINE: Patients and caregivers are randomized to 1 of 3 groups.
GROUP I: Patients and caregivers receive standard of care.
GROUP II: Patients and caregivers receive a 20-minute self-playing interactive educational video brochure.
GROUP III: Patients and caregivers receive a 20-minute self-playing interactive educational video brochure and watch a 20-minute interactive mindfulness exercise video.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 94
- Patient diagnosed with colorectal cancer
- Patients with at least one more chemotherapy appointment at the time of enrollment
- if patients have a caregiver, patients should agree to bring a caregiver to one of their hospital visits or have the caregiver schedule a separate study visit
- Ability to understand and the willingness to sign a written informed consent
- Illiterate participants
- Deaf participants
- Participants that do not read speak or understand either Spanish or English
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group II (educational video) educational intervention Patients and caregivers receive a 20-minute self-playing interactive educational video brochure. Group II (educational video) questionnaire administration Patients and caregivers receive a 20-minute self-playing interactive educational video brochure. Group III (educational video, mindfulness exercise video) questionnaire administration Patients and caregivers receive a 20-minute self-playing interactive educational video brochure and watch a 20-minute interactive mindfulness exercise video. Group III (educational video, mindfulness exercise video) CAM exercise therapy Patients and caregivers receive a 20-minute self-playing interactive educational video brochure and watch a 20-minute interactive mindfulness exercise video. Group II (educational video) caregiver-related intervention or procedure Patients and caregivers receive a 20-minute self-playing interactive educational video brochure. Group II (educational video) laboratory biomarker analysis Patients and caregivers receive a 20-minute self-playing interactive educational video brochure. Group III (educational video, mindfulness exercise video) educational intervention Patients and caregivers receive a 20-minute self-playing interactive educational video brochure and watch a 20-minute interactive mindfulness exercise video. Group III (educational video, mindfulness exercise video) caregiver-related intervention or procedure Patients and caregivers receive a 20-minute self-playing interactive educational video brochure and watch a 20-minute interactive mindfulness exercise video. Group III (educational video, mindfulness exercise video) laboratory biomarker analysis Patients and caregivers receive a 20-minute self-playing interactive educational video brochure and watch a 20-minute interactive mindfulness exercise video.
- Primary Outcome Measures
Name Time Method Change in self-reported stress levels assessed using pre- and post-test assessments Baseline to up to 60 minutes The intervention effects will be examined using multi-level modeling (MLM). These analyses will include chi-square, t-tests, and one way analyses of variance (ANOVAs).
Change in colorectal cancer knowledge assessed using pre- and post-test assessments Baseline to up to 60 minutes The intervention effects will be examined using multi-level modeling (MLM). These analyses will include chi-square, t-tests, and one way ANOVAs.
- Secondary Outcome Measures
Name Time Method Changes in salivary cortisol levels using chemiluminescence immunoassay Baseline to up 60 minutes Cortisol slopes will be calculated with two distinct areas under the curve analyses using the trapezoid formula as outlined by Pruessner 2003. Data values will be entered into a two factor (group by time) multilevel MIXED linear regression model to calculate differences between the three groups. A Scheffe post hoc test will be employed to determine the direction of the differences between the groups.
Trial Locations
- Locations (1)
USC Norris Comprehensive Cancer Center
🇺🇸Los Angeles, California, United States